Mark Wingertzahn

Mark Wingertzahn

Chief Tech/Sci/R&D Officer at WESANA HEALTH HOLDINGS INC.

53 year
Health Technology
Consumer Services

Profile

Mark Wingertzahn is currently an Associate Professor at the New York Institute of Technology, a Vice President-Research & Development at GlaxoSmithKline, Inc., the Head-Global Clinical Research at Pfizer Consumer Healthcare, and the Chief Scientific Officer at Wesana Health Holdings, Inc. He previously worked as the Head-Development and SVP-Research & Development at Kaleido Biosciences, Inc.

Mark Wingertzahn active positions

CompaniesPositionStart
WESANA HEALTH HOLDINGS INC. Chief Tech/Sci/R&D Officer 20/05/2021
New York Institute of Technology Corporate Officer/Principal -
Chief Tech/Sci/R&D Officer -
Chief Tech/Sci/R&D Officer -
All active positions of Mark Wingertzahn

Former positions of Mark Wingertzahn

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mark Wingertzahn's experience

Connections

30

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
KALEIDO BIOSCIENCES, INC.

Health Technology

WESANA HEALTH HOLDINGS INC.

Health Technology

Private companies2

Health Technology

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Mark Wingertzahn